[New possibilities of prognosis, therapy and prophylaxis of hemolytic disease of the newborn].
D000017:ABO Blood-Group System; D000653:Amniotic Fluid / Q000032:analysis; D001787:Blood Group Incompatibility; D001805:Blood Transfusion, Intrauterine; D002585:Cesarean Section; D004899:Erythroblastosis, Fetal / Q000517:prevention & control* / Q000628:therapy*; D005260:Female; D005333:Fetus / Q000000981:diagnostic imaging; D006801:Humans; D007231:Infant, Newborn; D008722:Methods; D011247:Pregnancy; D011379:Prognosis; D011859:Radiography; D012204:Rh-Hr Blood-Group System / Q000627:therapeutic use; D013053:Spectrophotometry
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System
Neue Möglichkeiten der Prognose, Therapie und Prophylaxe des Morbus haemolyticus neonatorum.